The People's Hospital of Kaizhou District, CQ
Welcome,         Profile    Billing    Logout  
 9 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
WU, Qiang
NCT05672537: Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Recruiting
2
70
RoW
Durvalumab, Surgery, Gemcitabine, Cisplatin
Tianjin Medical University Cancer Institute and Hospital
Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis
12/24
12/25
NCT05547256: A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

Active, not recruiting
N/A
54
RoW
COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose, COVID-19 Variant (Omicron BA.5) mRNA Vaccine High dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
12/22
03/24
NCT05550142: A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

Active, not recruiting
N/A
54
RoW
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine High dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
12/22
03/24
NCT05547243: A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

Active, not recruiting
N/A
350
RoW
SARS-CoV-2 mRNA Vaccine, Bivalent Low dose, SARS-CoV-2 mRNA Vaccine, Bivalent High dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
12/22
03/24
NCT05549206: A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

Not yet recruiting
N/A
350
NA
SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
04/23
04/24
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults

Recruiting
N/A
2400
RoW
Carotid ultrasound examination 1, Carotid ultrasound examination 2
First Hospital of China Medical University
Carotid Artery Diseases
08/23
07/24
NCT05745545: Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over

Recruiting
N/A
3200
RoW
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution
AIM Vaccine Co., Ltd., First Affiliated Hospital Bengbu Medical College, Ningbo Rongan Biological Pharmaceutical Co. Ltd.
SARS-CoV-2
09/23
11/23
NCT06422052: Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms

Recruiting
N/A
2242
RoW
Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)
Shanghai Jiao Tong University School of Medicine
Helicobacter Pylori Infection, Dyspepsia
05/25
05/25
NCT06039748: Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study

Not yet recruiting
N/A
330
NA
AngioQFA
Shenzhen Raysight Intelligent Medical Technology Co., Ltd., Renmin Hospital of Wuhan University, Yan'an Affiliated Hospital of Kunming Medical University, Sir Run Run Shaw Hospital, The Eighth Affiliated Hospital of Sun Yat-sen University, Jieyang People's Hospital
Coronary Artery Disease, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Coronary Stenosis, Vascular Diseases, Ischemia
10/24
10/24
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
WU, Qiang
NCT05672537: Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Recruiting
2
70
RoW
Durvalumab, Surgery, Gemcitabine, Cisplatin
Tianjin Medical University Cancer Institute and Hospital
Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis
12/24
12/25
NCT05547256: A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

Active, not recruiting
N/A
54
RoW
COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose, COVID-19 Variant (Omicron BA.5) mRNA Vaccine High dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
12/22
03/24
NCT05550142: A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

Active, not recruiting
N/A
54
RoW
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine High dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
12/22
03/24
NCT05547243: A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

Active, not recruiting
N/A
350
RoW
SARS-CoV-2 mRNA Vaccine, Bivalent Low dose, SARS-CoV-2 mRNA Vaccine, Bivalent High dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
12/22
03/24
NCT05549206: A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

Not yet recruiting
N/A
350
NA
SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high dose, Placebo
AIM Vaccine Co., Ltd., Ningbo Rongan Biological Pharmaceutical Co. Ltd., First Affiliated Hospital Bengbu Medical College
SARS-CoV-2
04/23
04/24
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults

Recruiting
N/A
2400
RoW
Carotid ultrasound examination 1, Carotid ultrasound examination 2
First Hospital of China Medical University
Carotid Artery Diseases
08/23
07/24
NCT05745545: Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over

Recruiting
N/A
3200
RoW
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution
AIM Vaccine Co., Ltd., First Affiliated Hospital Bengbu Medical College, Ningbo Rongan Biological Pharmaceutical Co. Ltd.
SARS-CoV-2
09/23
11/23
NCT06422052: Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms

Recruiting
N/A
2242
RoW
Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)
Shanghai Jiao Tong University School of Medicine
Helicobacter Pylori Infection, Dyspepsia
05/25
05/25
NCT06039748: Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study

Not yet recruiting
N/A
330
NA
AngioQFA
Shenzhen Raysight Intelligent Medical Technology Co., Ltd., Renmin Hospital of Wuhan University, Yan'an Affiliated Hospital of Kunming Medical University, Sir Run Run Shaw Hospital, The Eighth Affiliated Hospital of Sun Yat-sen University, Jieyang People's Hospital
Coronary Artery Disease, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Coronary Stenosis, Vascular Diseases, Ischemia
10/24
10/24
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28

Download Options